Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 2.24% is 65% above its 5-year average of 1.35%, around the middle of its 5-year range (0.19%–5.00%).
As of the fiscal period ended Tuesday, June 30, 2026. 24.75% below its 12-month average of 2.97%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.24%.
DEBT TO ASSETS RATIO
2.24%
DEBT TO ASSETS RATIO AVG TTM
2.97%
DEBT TO ASSETS RATIO AVG 3Y
1.71%
DEBT TO ASSETS RATIO AVG 5Y
1.35%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-24.75%
CURRENT VS 3Y AVG
+30.95%
CURRENT VS 5Y AVG
+65.21%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 846 covered companies
CURRENT VS SECTOR MEDIAN
+2386.32%
vs the sector median at left
IDEAYA Biosciences, Inc.
Market Cap
$3.47B
Debt to Assets Ratio
2.24%
TTM Avg
2.97%
3Y Avg
1.71%
5Y Avg
1.35%
Market Cap
$3.47B
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.49B
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.40B
Debt to Assets Ratio
0.06%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.40B
Debt to Assets Ratio
0.04%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.55B
Debt to Assets Ratio
0.67%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IDEAYA Biosciences, Inc. (IDYA) | $3.47B | 2.24% | 2.97% | 1.71% | 1.35% |
| Xenon Pharmaceuticals Inc. (XENE)vs › | $3.47B | 0.00% | N/A | N/A | N/A |
| Celcuity Inc. (CELC)vs › | $3.47B | 0.91% | N/A | N/A | N/A |
| Tango Therapeutics, Inc. (TNGX)vs › | $3.49B | 0.03% | N/A | N/A | N/A |
| Veracyte, Inc. (VCYT)vs › | $3.52B | 0.03% | N/A | N/A | N/A |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.40B | 0.06% | N/A | N/A | N/A |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.40B | 0.04% | N/A | N/A | N/A |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.55B | 0.67% | N/A | N/A | N/A |
| CareDx, Inc (CDNA)vs › | $3.38B | 0.04% | N/A | N/A | N/A |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.33B | 0.04% | N/A | N/A | N/A |
Debt/Assets
2.2%
Debt/Equity
0.02
Current Ratio
10.45
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 2.24% |
| 2026-03-31 | 2.78% |
| 2025-12-31 | 5.00% |
| 2025-09-30 | 2.30% |
| 2025-06-30 | 2.55% |
| 2025-03-31 | 2.36% |
| 2024-12-31 | 1.71% |
| 2024-09-30 | 1.52% |
| 2024-06-30 | 0.19% |
| 2024-03-31 | 0.25% |
| 2023-12-31 | 0.44% |
| 2023-09-30 | 0.39% |
| 2023-06-30 | 0.49% |
| 2023-03-31 | 0.83% |
| 2022-12-31 | 0.90% |
| 2022-09-30 | 0.95% |
| 2022-06-30 | 1.29% |
| 2022-03-31 | 1.33% |
| 2021-12-31 | 1.36% |
| 2021-09-30 | 1.40% |
| 2021-06-30 | 1.82% |
| 2021-03-31 | 1.95% |
| 2020-12-31 | 2.25% |
| 2020-09-30 | 2.35% |
| 2020-06-30 | 3.37% |
| 2020-03-31 | 6.38% |
| 2019-12-31 | 5.99% |
| 2019-09-30 | 5.76% |
| 2019-06-30 | 5.58% |
| 2019-03-31 | 8.35% |
| 2018-12-31 | 0.00% |
